Cliff Molife

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Systematic Review

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Future oncology (London, England)

Drugs - real world outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Cliff Molife, Alan Brnabic, Victoria J Stefaniak, Mark A Belger, Kristi Gruver, Jing Voon Chen, Saman Souri, George R Blumenschein
Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysis. Immunotherapy (2023)
Cliff Molife, Alan Brnabic, Victoria J Stefaniak, Mark A Belger, Kristi Gruver, Jing Voon Chen, Saman Souri, George R Blumenschein
Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysis. Immunotherapy 15 (4) (2023)
Cliff Molife, Alan Brnabic, Victoria J Stefaniak, Mark A Belger, Kristi Gruver, Jing Voon Chen, Saman Souri, George R Blumenschein
Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysis. Immunotherapy 15 (4) (2023)
Cliff Molife, Alan Brnabic, Victoria J Stefaniak, Mark A Belger, Kristi Gruver, Jing Voon Chen, Saman Souri, George R Blumenschein
Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysis. Immunotherapy 15 (4) (2023)
Misako Nagasaka, Cliff Molife, Zhanglin Lin Cui, Victoria Stefaniak, Xiaohong Li, Sangmi Kim, Hsui-Yung Lee, Julia Beyrer, George Blumenschein
Generalizability of ORIENT-11 trial results to a US standard-of-care cohort with advanced non-small-cell lung cancer. Future oncology (London, England) 18 (16) (2022)
Cliff Molife, Jae Min Cho, Jennifer Lapthorn, Min Ju Kang, Yulia D'yachkova, Sangmi Kim, Sam Colman, Saerom Kim, Agota Szende, Ji Hyun Park, Hee Kyung Ahn, Min Hee Hong, Kaisa-Leena Taipale, Hye Ryun Kim
Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea. Drugs - real world outcomes (2022)
Michael Grabner, Cliff Molife, Liya Wang, Katherine B Winfree, Zhanglin Lin Cui, Gebra Cuyun Carter, Lisa M Hess
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration. JMIR cancer 7 (2) (2021)
Katherine B Winfree, Cliff Molife, Patrick M Peterson, Yongmei Chen, Carla M Visseren-Grul, Mark S Leusch, Julie Beyrer, Anastasios Dimou
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations. Future oncology (London, England) 17 (22) (2021)